THE ASSOCIATION OF ENDOSCOPIC AND HISTOLOGIC ENDPOINTS WITH FAECAL CALPROTECTIN AND C-REACTIVE PROTEIN IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH MIRIKIZUMAB

Remo Panaccione  ¹     Christophe Sapin  ²     Faye Chan-Diehl     Richard Moses     Britta Siegmund  ³     Alissa Walsh  ⁴     Taku Kobayashi  ⁵     Parambir Dulai  ⁶     Simon Travis  ^7    
1 University of Calgary, Calgary, Canada
² Eli Lilly and Company, Indianapolis, United States
³ Charité - Universitätsmedizin Berlin, Berlin, Germany
⁴ St Vincent's Hospital, Sydney, Australia
⁵ Kitasato University Kitasato Institute Hospital, Minato-ku, Japan
⁶ University of California San Diego, La Jolla, United States
⁷ John Radcliffe Hospital, Oxford, United Kingdom

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)